Crabel Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,083
Closed -$7.87M 119
2022
Q3
$7.87M Hold
52,083
4.6% 2
2022
Q2
$7.59M Buy
+52,083
New +$7.59M 3.98% 3